650.2000 -0.80 (-0.12%)
NSE Jan 01, 2026 15:50 PM
Volume: 148.2K
 

650.20
-0.12%
Angel Broking
Unique investment opportunity in drug research business: While almost all Indian pharma companies are in generic drugs business, Syngene supports its clients to invent new drugs. It has 8 of the top 10 global pharma companies as its clients and also has long term contracts with some big pharma companies. In our view Syngene provides a uni..
Syngene International Ltd.'s price crossed below 50Day SMA today
More from Syngene International Ltd.
Recommended